Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2004
08/05/2004WO2004065333A2 Organic, metallorganic and biological material obtained from rock
08/05/2004WO2004064853A1 Cordyceps capsule and method for preparation thereof
08/05/2004WO2004064776A2 Methods of preparation of live attenuated bacterial vaccines by alteration of dna adenine methylase (dam) activity in those bacteria
08/05/2004WO2004064774A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/05/2004WO2004050869A8 PROTEIN BINDING TO Akt2
08/05/2004WO2004043881A3 A method to produce succinic acid from raw hydrolysates
08/05/2004WO2004041216A3 Ptpn11 (shp-2) mutations and cancer
08/05/2004WO2004037976A3 NONSENSE-MEDIATED mRNA DECAY
08/05/2004WO2004024283A3 Apparatus and method for preparative scale purification of nucleic acids
08/05/2004WO2003060093A3 METHODS AND COMPOSITIONS FOR PROPAGATING VECTORS CONTAINING TOXIC cDNAs AND ION CHANNEL ASSAY SYSTEMS
08/05/2004WO2003057842A3 Aggrecanase molecules
08/05/2004WO2003057830A3 Compositions and methods for hydroxylating epothilones
08/05/2004WO2003044185A3 Purified polypeptides involved in general metabolism
08/05/2004WO2003042359A3 Histamine receptor h3 polynucleotides
08/05/2004WO2003029411A3 Novel cyclooxygenase variants and methods of use
08/05/2004WO2002074926A3 Myo-inositol oxygenases
08/05/2004US20040152876 Immunogenic HBc chimer particles having enhanced stability
08/05/2004US20040152871 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders
08/05/2004US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus
08/05/2004US20040152184 Transgenic escherichia comprising F' particle and enhanced gene transfer efficieny for use as diagnostic and prognostic tools in gene transfer protocal; bioreactors
08/05/2004US20040152177 Nutrient broth comprising metabolizable carbon source, inorganic nitrogen, phosphates, transition metals, biotin and microorganism for generating dicarboxylic acids; bioreactors
08/05/2004US20040152175 Method for producing L-glutamine and L-glutamine producing bacterium
08/05/2004US20040152174 Genetically modified eschrichia strain which is capable of biocoversion a single cacrbon source into 1, 3 propanediol using fermentation; bioreactors
08/05/2004US20040152173 Using bacillus culture to generate vitamin b5; bioreactors
08/05/2004US20040152171 Propagating escherichia mutant which produces 5'-inosinic acid or 5'-guanylic acid; identifying nucleotidase gene associated with generating nucleoside 5'-phosphate esters
08/05/2004US20040152165 Lipopolysaccharide alpha -2,3 sialyltransferase of campylobacter jejuni and its uses
08/05/2004US20040152164 62 human secreted proteins
08/05/2004US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems
08/05/2004US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders
08/05/2004US20040152159 Materials and methods for the efficient production of acetate and other products
08/05/2004US20040152157 G-protein coupled receptors
08/05/2004US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease
08/05/2004US20040152143 Growth differentiation factor-9
08/05/2004US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering
08/05/2004US20040152131 Methods for end point temperature testing
08/05/2004US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering
08/05/2004US20040152115 directed toward modulating oxidative damage to intracellular components such as mitochondrial DNA (mtDNA) and mitochondrial protein
08/05/2004US20040152101 for diagnostic/therapeutic/prophylactics for neurodegenerative diseases, brain dysfunctions, cancers, gastrointestinal/circulatory/endocrine diseases and cell death; genetic engineering
08/05/2004US20040152099 for the preparation of a live carrier for the expression of at least one heterologous antigen or of a live vaccine; for in vivo drug screening
08/05/2004US20040152092 Cancer therapy, cardiovascular disorders, central nervous system disorders, asthma, antidiabetic agents
08/05/2004US20040152088 Methods for diagnosing and treating heart disease
08/05/2004US20040152078 Genetic engineering
08/05/2004US20040152067 Impedance based apparatuses and methods for analyzing cells and particles
08/05/2004US20040151736 Use of cross-protection to identify novel vaccine candidates for infectious agents
08/05/2004US20040151725 nucleic acid encoding a peptide with a CTLA4 extracellular domain and a peptide with an an immunoglobulin constant region; hinge region is modified to reduce complement activation or Fc receptor interaction; immunosuppressants
08/05/2004US20040151720 Cell surface molecule mediating cell adhesion and signal transmission
08/05/2004US20040151708 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and anti-oxidative probiotic
08/05/2004US20040151698 Microbial pesticide active against plant fungal pathogens and process for preparation thereof
08/05/2004US20040151695 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
08/05/2004US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens
08/05/2004US20040151620 Rapid sterilization and vaccine preparation
08/05/2004CA2517469A1 .beta.1,3-n-acetyl-d-galactosaminyltransferase protein and nucleic acid encoding the same, as well as canceration assay using the same
08/05/2004CA2513642A1 Diagnosis and prognosis of breast cancer patients
08/05/2004CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
08/05/2004CA2512144A1 Solid surface for biomolecule delivery and high-throughput assay
08/04/2004EP1443056A1 IL-6 receptor.IL-6 direct fusion protein
08/04/2004EP1442295A2 Periostin-based diagnostic assays
08/04/2004EP1442134A2 Method for producing and identifying soluble protein domains
08/04/2004EP1442128A2 Production, detection and use of transformant cells
08/04/2004EP1442124A1 Polypeptide antigen forming a mimetic structure of the gp41 intermediate state
08/04/2004EP1442123A2 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
08/04/2004EP1442121A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
08/04/2004EP1442120A2 Alkaline protease variants and detergents and cleansers containing these alkaline protease variants
08/04/2004EP1442115A2 METHODS OF ISOLATION, EXPANSION AND DIFFERENTIATION OF FETAL STEM CELLS FROM CHORIONIC VILLUS, AMNIOTIC FLUID, AND PLACENTA AND THERAPEUTIC USES THEREOF
08/04/2004EP1442114A2 Novel bacterial poultry disease
08/04/2004EP1442113A1 Mixture of propionibacterium jensenii and lactobacillus sp. with antimicrobial activities for the use as natural preservation system
08/04/2004EP1442112A1 Optoinjection methods
08/04/2004EP1442064A2 Kinases and phosphatases
08/04/2004EP1442060A2 A novel g protein-coupled receptor, gave 10
08/04/2004EP1442055A1 Aequorin as a growth marker in yeast
08/04/2004EP1442054A1 Aequorin as a reporter gene in yeast
08/04/2004EP1442052A1 High level constitutive production of anthrax protective antigen
08/04/2004EP1442047A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/04/2004EP1442046A2 Mammalian c-type lectins
08/04/2004EP1442045A2 Isolation and purification of nucleic acids
08/04/2004EP1441852A2 Method for forming catalytic sites at the surface of a support
08/04/2004EP1441849A1 Sorptive composite materials
08/04/2004EP1133564B1 Zace1: a human metalloenzyme
08/04/2004EP1129212B1 Screening process for antibacterial agents
08/04/2004EP1071745B1 Process for synthesizing cox-2 inhibitors
08/04/2004EP1070136B1 Strain of the microorganism penicillium oxalicum var. armeniaca and its application
08/04/2004EP0922108B1 Novel expression vectors
08/04/2004EP0790835B1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
08/04/2004EP0725829B1 Methods and compositions for high protein production from recombinant dna
08/04/2004CN1518601A Process for producing riboflavin
08/04/2004CN1518598A Serpin in Bifidobacteria
08/04/2004CN1518592A Male contraceptives
08/04/2004CN1518559A VHH single heavy chain antibody and method for its preparation in mammal
08/04/2004CN1517436A Oxide-reductase
08/04/2004CN1160469C Identification of genes
08/04/2004CN1160465C Funguns wherein areA, pepC and/or pepE genes have been inactivated
08/04/2004CN1160464C Process for preparing human muscle hemoglobin by gene recombination
08/04/2004CN1160461C Glucanse gene and lichenbacillus
08/04/2004CN1160457C Recombinant mistletoe lectin (rML)
08/04/2004CN1160456C Method for stabilizing nitrilase activity and preserving microbial cells
08/04/2004CN1160452C A strain of recombined broad spectrum bacillus thuringiensis
08/04/2004CN1160451C Rhamnose lactic acid bacteria strain and its use
08/04/2004CN1160450C Full-synthetic culture medium and its application method
08/04/2004CN1160449C Artificially cultured schizophyllum sporophores and its cultrue process
08/04/2004CN1160448C Prokaryotic cell comprising two copies of gene transcribed in different directions